Home / Science / Cancer Breakthrough: Liquid Biopsy Detects Early Stages
Cancer Breakthrough: Liquid Biopsy Detects Early Stages
22 Feb
Summary
- Microscopic vesicles called exosomes act as biomarkers for early cancer detection.
- Liquid biopsies using exosomes may detect aggressive cancers before scans.
- Targeting tumor structures could stop cancer metastasis and improve survival.
Scientist Raghu Kalluri unveiled a novel method for early cancer detection on Sunday, February 22, at the SPARC Cancer Research Conclave-II. His research utilizes exosomes, microscopic vesicles released by cells, as biomarkers to develop "liquid biopsies."
Decoding messages within exosomes in the blood could allow for the early detection of aggressive cancers, such as pancreatic cancer, long before traditional scans can identify them. This approach aims to catch the disease in its most treatable stages.
Furthermore, Kalluri's work targets the structural framework surrounding tumors, specifically fibroblasts and collagen. This strategy holds the potential to halt cancer metastasis, which is currently the primary cause of cancer-related deaths.
Kalluri urged the scientific community to shift focus from treating advanced disease to "intercepting" cancer. He believes the future of oncology lies in non-invasive monitoring, transforming cancer into a manageable condition.
